This site is intended for Healthcare Professionals only.

Tag: NICE

NICE recommends faricimab as treatment option for two forms of sight loss

The National Institute for Health and Care Excellence (NICE) has recommended faricimab as treatment option for adults with wet age-related macular degeneration or diabetic...

NICE recommends innovative technology to show if breast cancer has spread

The National Institute of Health and Care Excellence has recommended that surgeons working in hospitals with limited or no access to a radiopharmacy department...

NICE recommends Tepotinib for advanced lung cancer

'Tepotinib’ has been recommended by the National Institute for Health and Care Excellence (NICE) to patients with a specific gene mutation of advanced non-small-cell...

ABPI welcomes NICE’s guidance on value of new antibiotics

The Association of the British Pharmaceutical Industry (ABPI) has welcomed the National Institute for Health and Care Excellence's leadership in introducing a new approach...

NICE says ‘highly effective’ breast cancer drug is ‘too expensive’ for NHS use

Sacituzumab govitecan, a 'highly effective' treatment for triple negative breast cancer, is not recommended by the National Institute for Health and Care Excellence (NICE)...

NICE recommends first new treatment ‘romosozumab’ for osteoporosis

The National Institute for Health and Care Excellence (NICE) has recommended first new treatment – ‘romosozumab’ for osteoporosis for over a decade. Thousands of people...